Citation Impact
Citing Papers
Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: A Literature Review and a Proposal for a Novel Approach to Improve Practice
2006
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
2006 Standout
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
2005
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Major depressive disorder
2016 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Glutamate receptor ion channels
2005 Standout
Glutamate and Depression
2003
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
DHEAS Deficiency During Consumption of Sustained-Action Prescribed Opioids: Evidence for Opioid-Induced Inhibition of Adrenal Androgen Production
2006
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
An emerging role for PtdIns(4,5)P2-mediated signalling in human disease
2005
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
2008
Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders
2003
Mammalian phosphoinositide kinases and phosphatases
2009 StandoutNobel
Schizophrenia
2009 Standout
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
2004
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia
2004
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels
2008
Major Depressive Disorder
2008 Standout
Beyond Monoamines: Glutamatergic Function in Mood Disorders
2005
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
2007
Phosphoinositides in cell regulation and membrane dynamics
2006 StandoutNature
Deep Transcranial Magnetic Stimulation as a Treatment for Psychiatric Disorders: A Comprehensive Review
2012
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
The Paradox of Quetiapine in Obsessive-Compulsive Disorder
2005
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Antiglucocorticoid treatments for mood disorders
2015
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
2004
How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications.
2010
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia
2006
The Physiology of Phosphoinositides
2007 StandoutNobel
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
The Metabolic Syndrome
2008 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Opioid Complications and Side Effects
2008 Standout
Works of Rafael Stryjer being referenced
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross‐over study
2004
Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors
2008
Clozapine in the Treatment of Obsessive-compulsive Symptoms in Schizophrenia Patients: A Case Series Study
2004
Amantadine as augmentation therapy in the management of treatment-resistant depression
2003
Response to deep TMS in depressive patients with previous electroconvulsive treatment
2009
Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p‐Linked Psychiatric Disorders
2003
Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia
2003